Documentos relacionados

1. Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.
2. First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphoma.
3. Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
4. Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients.
5. Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial.
6. Follicular lymphoma: 2023 update on diagnosis and management.
7. The impact of histological grade on outcomes in follicular lymphoma: An analysis of patients in the SEER database in the context of evolving disease classification and treatment.
8. Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice.
9. Time for an individualized approach to first-line management of follicular lymphoma.
10. Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.